- Ongoing active urology follow-up
- Any blood tests requested should be added to ordercomms by urology
- Results should go to urology
Prostate cancer shared care
This is a summary of the follow-up guidance for practices taking part in the Local Enhanced Service for prostate cancer shared care.
At point of transfer to shared care, the urologist will clearly identify the schedule to follow by specifying which of the groups below apply to that patient.
Criteria for discharge to shared care:
- PSA nadir < 0.1 mcg/l
- Asymptomatic
PSA testing regime:
- Every 3 months for first year
- Every 6 months for second and third year
- Annually thereafter
Refer back to urology if:
- PSA 0.2 mcg/l or higher and remains so after repeat in 8 weeks
- Troublesome symptoms
Criteria for discharge to shared care:
- PSA nadir < 2 mcg/l or stable PSA
- Asymptomatic
PSA testing regime:
- Every 3 months for first year
- Every 6 months for second and third year
- Annually thereafter
Refer back to urology if:
- PSA > 2 mcg/l above nadir
- Troublesome symptoms
Criteria for discharge to shared care:
- PSA nadir < 2 mcg/l
- Asymptomatic
Note these patients are followed up by WGH team so advice will be from there.
Criteria for discharge to shared care:
- PSA nadir < 10 mcg/l
- Or stable PSA >10 (letter will stipulate)
- Asymptomatic
PSA testing regime:
- Every 3 months for first year
- Every 6 months thereafter
Refer back to urology if:
- PSA doubled from baseline
- Troublesome symptoms
Criteria for discharge to shared care:
- PSA nadir < 10 mcg/l
- Or stable PSA >10 (letter will stipulate)
- Asymptomatic
PSA testing regime:
- Every 3 months for first year
- Every 6 months thereafter if stable
Refer back to urology if:
- Doubling of PSA from baseline
- Troublesome symptoms